<DOC>
	<DOCNO>NCT02529410</DOCNO>
	<brief_summary>100 pt multicentre study 50 pt randomise triventricular pacemaker , 50 biventricular pacemaker Feasibility study 6 month outcome data</brief_summary>
	<brief_title>Standard Care Versus Triventricular Pacing Heart Failure</brief_title>
	<detailed_description>100 patient QRS duration ( 120-150ms LBBB ) device insertion per ESC guideline 2013 recruit study 10 centre . Patients undergo pre-operative work typical institution ( example GSTT site include cardiac MRI , cardiopulmonary exercise testing ( CPET ) , 6 minute walk test , blood include Nt pro BNP , Minnesota live heart failure questionnaire ( MLWHFQ ) , 2D/3D echocardiogram collection demographic data . ) Patients randomise 1:1 fashion receive either Triventricular device conventional biventricular device . Participants follow per implant institution 's typical follow . ( example GSTT include 6 week atrio-ventricular ventricular-ventricular optimisation ( patient device autooptimise ) review clinician well 6 month follow point CPET , 6 minute walk test , MLWHFQ , blood include Nt pro BNP , 2D/3D echocardiogram collection demographic data repeat . ) Regardless institution 's follow , 6 week ( 4-8 week ) 6 month ( 5-9month ) follow appointment form part study protocol . The 6 week check take form standard clinical pacing check physician input deem necessary per host institution 's usual standard care/ ( usually one would imagine problem therapy delivery note ) The 6 month follow allow patient device follow . This require 2D echocardiography , 6 min walk test , MLWHFQ NtproBNP measurement . Where possible institution encourage perform CPET 3D echocardiography pre implant 6 month . For determine `` response rate '' , positive response define absolute reduction LVESV 15 % . In order determine magnitude response change LVESV assess continuous variable .</detailed_description>
	<mesh_term>Heart Failure</mesh_term>
	<criteria>Class 1b Indication CRT ( LBBB QRS120150ms ) per ESC guideline 2013 Participant willing able give inform consent participation study . Male Female , age 18 year . Female participant child bear potential must willing ensure partner use effective contraception study 3 month thereafter Able ( Investigators opinion ) willing comply study requirement . Willing allow General Practitioner consultant , appropriate , notified participation study . Female participant pregnant , lactate plan pregnancy course study . Any significant disease disorder , opinion Investigator , may either put participant risk participation study , may influence result study , participant 's ability participate study . Insufficient capacity consent study QRS &gt; 150ms NonLBBB morphology 120150ms</criteria>
	<gender>All</gender>
	<minimum_age>18 Years</minimum_age>
	<maximum_age>N/A</maximum_age>
	<verification_date>February 2016</verification_date>
</DOC>